You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: July 2021 to March 2024

AbstractFullPdf
Jul 2021936936225
Aug 202137437655
Sep 202116216255
Oct 202114314539
Nov 202110910928
Dec 2021848825
Jan 2022596922
Feb 2022474920
Mar 2022989921
Apr 2022767820
May 2022525228
Jun 2022596615
Jul 2022484921
Aug 2022555716
Sep 2022424421
Oct 2022495427
Nov 2022474812
Dec 202236365
Jan 2023484811
Feb 2023676824
Mar 2023515326
Apr 2023252514
May 202317176
Jun 202333337
Jul 2023252520
Aug 2023313211
Sep 2023282813
Oct 2023242411
Nov 2023292913
Dec 2023323313
Jan 2024202110
Feb 2024404025
Mar 2024313126
Total29773024885